Joanna Horobin's most recent trade in Liquidia Corp was a trade of 18,396 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Liquidia Corp | Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 18,396 | 38,755 (0%) | 0% | 0 | Common Stock | |
Liquidia Corp | Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 20,359 (0%) | 0% | 0 | Common Stock | |
Kymera Therapeutics Inc | Joanna Horobin | Director | 07 Jun 2024 | 8,500 | 8,500 | - | 2.1 | 17,680 | Common Stock | |
Kymera Therapeutics Inc | Joanna Horobin | Director | 07 Jun 2024 | 8,500 | 33,195 | - | - | Stock Option (Right to Buy) | ||
Kymera Therapeutics Inc | Joanna Horobin | Director | 07 Jun 2024 | 6,313 | 0 | - | 33.1 | 209,005 | Common Stock | |
Kymera Therapeutics Inc | Joanna Horobin | Director | 07 Jun 2024 | 2,187 | 6,313 | - | 32.6 | 71,395 | Common Stock | |
Liquidia Corp | Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Kymera Therapeutics Inc | Joanna Horobin | Director | 15 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | ||
Liquidia Corp | Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Kymera Therapeutics Inc | Joanna Horobin | Director | 15 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | ||
Liquidia Corp | Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Kymera Therapeutics Inc | Joanna Horobin | Director | 16 Jun 2021 | 20,063 | 20,063 | - | - | Stock Option (Right to Buy) | ||
Liquidia Corp | Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 35,872 | 35,872 | - | - | Non-Qualified Stock Option (right to buy) | |
Kymera Therapeutics Inc | Joanna Horobin | Director | 20 Aug 2020 | 40,127 | 40,127 | - | - | Stock Option (Right to Buy) |